4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-020263
Chief Financial Officer gave up 1,352 shares (to pay taxes)
- Chief Financial Officer acquired 2,833 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TOMSICEK MICHAEL JOHN Chief Financial Officer | 2021-03-10 | Option exercise | +2,833 | 3,243 | D | ||
| TOMSICEK MICHAEL JOHN Chief Financial Officer | 2021-03-10 | Shares withheld for taxes | −1,352 | $124.15 | $167,851 | 1,891 | D |
| Derivatives | |||||||
| TOMSICEK MICHAEL JOHN Chief Financial Officer | 2021-03-11 | Grant or award · Stock Option (Right to Buy) | +25,360 | 25,360 | D | ||
| TOMSICEK MICHAEL JOHN Chief Financial Officer | 2021-03-11 | Grant or award · Restricted Stock Units | +9,000 | 9,000 | D | ||
Loading xslF345X03/doc4.xml…